Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
ABMT stock price ended at $0 on 金曜日, after rising NaN%
On the latest trading day Feb 27, 2026, the stock price of ABMT rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 3.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 150 shares were traded, amounting to a market value of approximately --.